Home >> WEBINARS >> MALDI-TOF for the clinical identification of mycobacteria

MALDI-TOF for the clinical identification of mycobacteria

Print Friendly, PDF & Email

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Webinar presenter Omai Garner, PhD, D(ABMM), Assistant Clinical Professor, Section Chief, Clinical Microbiology, Director, Point of Care Testing, UCLA Department of Pathology and Laboratory Medicine,  discusses the implementation and clinical use of MALDI-TOF MS for mycobacterial identification. It covers in detail the clinical data surrounding organism identification. It also explores the lab protocol (workflow impact) and turnaround time improvements (clinical impact) for this new technology. This on-demand webinar originally broadcast on December 13, 2018.

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from bioMérieux, Inc.

x

Check Also

Current and emerging biomarkers: science, technologies, and practicalities

Webinar presenter Tabetha Sundin, PhD, HCLD, MB, discusses the crucial role pathologists play in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This webinar will empower you to understand the biology behind current and emerging immuno-oncology biomarkers. This on-demand webinar originally broadcast on October 3, 2018.

X